Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Comment by quintessenceon Oct 31, 2016 7:58pm
187 Views
Post# 25408078

RE:Valeant - News Release (BS Rumours)

RE:Valeant - News Release (BS Rumours)Well, surprised at the drop of the obvious. I really thought this was all built into the price. Same as a possible drop in earnings guidance.
I would also think that the other obvious is, is that the company has been cooperating with authorities. It could be that the company wanted to get all the ugly stuff out now in this quarter. Could it be they leaked info? That will allow them a clean slate to build with Papa at the helm now that Papa is starting to figure out what needs to be done. Conjecture for sure.
Papa stated somewhere he was planning on reducing debt by 5-8 billion by selling off assets and some of these should be high lited by end of year.
VRX has a lot of revenue and profit moving in which over time will resolve many issues.
You can bet Pershing is being aggressive at resolving issues.

Will we get a bit of a V return?  We're at the short end of evaluation now.

All IMO.
<< Previous
Bullboard Posts
Next >>